Cargando…
The safe use of inflammatory bowel disease therapies during the COVID-19 pandemic
BACKGROUND: Patients with inflammatory bowel disease (IBD) often require the use of immunosuppressant medications that increase infection risk, leading to concerns over the safe use of IBD medications during the Coronavirus 19 (COVID-19) pandemic. OBJECTIVES: To summarize available evidence on the s...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040409/ https://www.ncbi.nlm.nih.gov/pubmed/35496814 http://dx.doi.org/10.1016/j.crphar.2022.100101 |